PATENT CLAIM ANALYSIS

Application Number: 15882504
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "400000"]

Abstract:
Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a T max  as quick as 2 minutes and not later than 30 minutes in the majority of subjects.

Claim (Index 6):
The system of  claim 1  wherein upon application of the system to a selected area of skin of the patient, the T max  of a therapeutically effective serum concentration occurs within about 20 minutes of the application.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.38889
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14497595', '12853922', '12608445', '13105562', '14280117']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.751706718348939
- 35 USC 102 Novelty (BERT): 0.5091240038123849
- Combined Prediction Score: 0.7274484468952835
- Mean Citation Score: 259.036516
- Max Citation Score: 269.51328
- Similarity Product: 186.23399365242005

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test